Liver Biopsy Market - Global Trends, Analysis, Covid19 Impact and Regional Forecast to 2023

Liver Biopsy Market Research Report: Information By Type (Percutaneous, Transjugular, Laparoscopic), Indication (Nonalcoholic Fatty Liver Disease, Chronic Hepatitis B Or C), End User (Hospitals & Clinics, Diagnostic Centers) – Global Forecast Till 2023

Market Highlights:

Liver biopsy is a diagnostic procedure for liver diseases, recommended when blood tests or diagnostic imaging might suggest a liver problem. It is of three major types namely percutaneous, transjugular, and laparoscopic. It is also used to monitor the liver condition during liver transplant and to determine complications if any. The healthcare provider may recommend liver biopsy if the patient is diagnosed with liver disease or identifies the presence of blood in the urine.

The global liver biopsy market is expected to grow at a CAGR of ~4.2% during the forecast period, 2017-2023.

Latest Free Sample PDF Available @ https://www.marketresearchfuture.com/sample_request/5534

Segmentation:

The global liver biopsy market is segmented on the basis of type, indication, and end user.

On the basis of the diagnosis, it is segmented into percutaneous, transjugular, and laparoscopic biopsy.

On the basis of indication, it is segmented into nonalcoholic fatty liver disease, chronic hepatitis B or C, autoimmune hepatitis, alcoholic liver disease, and others.

Based on the end user, it is segmented into hospitals & clinics, tertiary care centers, urology centers, and others.

Intended Audience

Research and Development (R&D) Companies
Ambulatory Care Centers
Academic Institutes and Universities
Biotechnology Companies
Medical Device Manufacturers
Medical Device Suppliers
Market Research and Consulting Service Providers
Potential Investors
Key Players:

Some of key the players in the market are Becton, Dickinson and Company, MDxHealth, Veran medical, Medtronic, Argon Medical Devices, Inc., Mauna Kea Technologies, Boston Scientific Corporation, Intact Medical Corp., C. R. Bard, Inc., Leica Biosystems, Cook Medical, RI.MOS., Hologic, Inc., Sterylab, INRAD Inc., Fujifilm Medical Systems, and others

Regional Analysis:

Globally, the Americas is the largest market for liver biopsy due to increasing awareness about the importance of biopsy for the diagnosis of liver disease. In the Americas, North America is the largest market with the U.S. capturing major share followed by Canada. Additionally, extensive use of technologically advanced medical devices for diagnosis and treatment of chronic liver disease, support from the government for research & development, and high health care spending drives the market growth. Additionally, increasing patient population with liver disease, diabetes, and other risk factors for renal failure is fuelling the market growth.

ACCESS THE FULL REPORT @ https://www.marketresearchfuture.com/reports/liver-biopsy-market-5534

More Healthcare Industry Related Reports

Zika Virus Testing Market - Global Forecast till 2023

https://www.marketresearchfuture.com/upcoming-reports/zika-virus-testing-market-5662

Healthcare Supply Chain Management Market - Global Forecast till 2023

https://www.marketresearchfuture.com/reports/healthcare-supply-chain-management-market-5716

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Contact:

Akash Anand

Market Research Future

Address: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune

+1 646 845 9312

Email: sales@marketresearchfuture.com

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

This release was published on openPR.